Literature DB >> 3552109

The role of insulin resistance in the pathogenesis of myotonic muscular dystrophy.

A J Hudson, M W Huff, C G Wright, M M Silver, T C Lo, D Banerjee.   

Abstract

A study of glucose, insulin, lipids and lipoproteins in myotonic dystrophy (MyD) has shown elevation of fasting plasma insulin, triglycerides and very low density lipoproteins (VLDL) but no significant difference from normal in the fasting plasma glucose, total cholesterol or low and high density lipoproteins. Elevation of the total triglyceride and VLDL levels showed a direct relationship to hyperinsulinaemia. Insulin binding to cultured MyD fibroblasts under optimal conditions was significantly reduced but there was no difference in receptor affinity between MyD and control cells. In contrast to insulin binding, LDL binding to MyD fibroblasts was normal although there was a tendency to reduced LDL binding at 37 degrees C that may reflect mildly reduced lipid metabolism. The alterations in lipids and insulin in MyD are compatible with insulin resistance. Laboratory and clinical findings in MyD were compared with other inherited insulin-resistant diseases. MyD showed marked similarity to a group of disorders that have mild insulin resistance and mildly elevated plasma insulin in contrast to others with severe hyperinsulinaemia and insulin resistance. It is suggested that at least some clinical features of MyD may be due to diminished overall effect of insulin or other trophic factors on cell metabolism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552109     DOI: 10.1093/brain/110.2.469

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  6 in total

1.  Deficiency of Na+/K(+)-ATPase and sarcoplasmic reticulum Ca(2+)-ATPase in skeletal muscle and cultured muscle cells of myotonic dystrophy patients.

Authors:  A A Benders; J A Timmermans; A Oosterhof; H J Ter Laak; T H van Kuppevelt; R A Wevers; J H Veerkamp
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

2.  RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance.

Authors:  A Morrone; E Pegoraro; C Angelini; E Zammarchi; G Marconi; E P Hoffman
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

3.  Muscleblind-like 3 deficit results in a spectrum of age-associated pathologies observed in myotonic dystrophy.

Authors:  Jongkyu Choi; Donald M Dixon; Warunee Dansithong; Walid F Abdallah; Kenneth P Roos; Maria C Jordan; Brandon Trac; Han Shin Lee; Lucio Comai; Sita Reddy
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

Review 4.  Cells of Matter-In Vitro Models for Myotonic Dystrophy.

Authors:  Magdalena Matloka; Arnaud F Klein; Frédérique Rau; Denis Furling
Journal:  Front Neurol       Date:  2018-05-23       Impact factor: 4.003

Review 5.  Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1.

Authors:  Sylvia Nieuwenhuis; Kees Okkersen; Joanna Widomska; Paul Blom; Peter A C 't Hoen; Baziel van Engelen; Jeffrey C Glennon
Journal:  Front Neurol       Date:  2019-11-26       Impact factor: 4.003

Review 6.  Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin.

Authors:  Tiago Mateus; Filipa Martins; Alexandra Nunes; Maria Teresa Herdeiro; Sandra Rebelo
Journal:  Int J Environ Res Public Health       Date:  2021-02-12       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.